Free Trial
NASDAQ:IVA

Inventiva (IVA) Stock Price, News & Analysis

Inventiva logo
$2.66
-0.10 (-3.62%)
(As of 10/31/2024 ET)

About Inventiva Stock (NASDAQ:IVA)

Key Stats

Today's Range
$2.65
$2.79
50-Day Range
$1.65
$2.76
52-Week Range
$1.53
$4.75
Volume
35,441 shs
Average Volume
80,428 shs
Market Capitalization
$139.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.67
Consensus Rating
Buy

Company Overview

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

Inventiva Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
53rd Percentile Overall Score

IVA MarketRank™: 

Inventiva scored higher than 53% of companies evaluated by MarketBeat, and ranked 577th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inventiva has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Inventiva has only been the subject of 2 research reports in the past 90 days.

  • Read more about Inventiva's stock forecast and price target.
  • Earnings Growth

    Earnings for Inventiva are expected to grow in the coming year, from ($2.25) to ($2.13) per share.

  • Percentage of Shares Shorted

    1.63% of the outstanding shares of Inventiva have been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Inventiva has recently increased by 562.06%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Inventiva does not currently pay a dividend.

  • Dividend Growth

    Inventiva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.63% of the outstanding shares of Inventiva have been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Inventiva has recently increased by 562.06%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Inventiva has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Inventiva this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for IVA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Inventiva to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inventiva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.00% of the stock of Inventiva is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.06% of the stock of Inventiva is held by institutions.

  • Read more about Inventiva's insider trading history.
Receive IVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inventiva and its competitors with MarketBeat's FREE daily newsletter.

IVA Stock News Headlines

Inventiva Gains Positive Nod for Lanifibranor Trial
War on Elon Escalates…
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
See More Headlines

IVA Stock Analysis - Frequently Asked Questions

Inventiva's stock was trading at $4.52 at the beginning of the year. Since then, IVA stock has decreased by 41.2% and is now trading at $2.66.
View the best growth stocks for 2024 here
.

Inventiva (IVA) raised $103 million in an initial public offering (IPO) on Friday, July 10th 2020. The company issued 7,500,000 shares at $13.68 per share. Jefferies, Stifel and Guggenheim Securities served as the underwriters for the IPO and H.C. Wainwright, Roth Capital Partners and KBC Securities were co-managers.

Shares of IVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inventiva investors own include Kinross Gold (KGC), Outlook Therapeutics (OTLK), Accuray (ARAY), Carnival Co. & (CCL), Alibaba Group (BABA), Palantir Technologies (PLTR) and PayPal (PYPL).

Company Calendar

Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IVA
Fax
N/A
Employees
100
Year Founded
2011

Price Target and Rating

Average Stock Price Target
$17.67
High Stock Price Target
$20.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+564.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$15.62 million
Book Value
($0.67) per share

Miscellaneous

Free Float
35,684,000
Market Cap
$139.59 million
Optionable
Not Optionable
Beta
0.96

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:IVA) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners